Study guide

7.1 Lower Respiratory Specimens, CAP, and HAP Pathogens

ASCP Microbiology Technologist M ASCP

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current M(ASCP) Exam Facts 1.2 CAT, Scoring, Retakes, and CMP 1.3 Eligibility Routes and Clinical Experience

2 Preanalytic: Collection and Transport

2.1 Patient Identification and Specimen Labeling 2.2 Specimen Collection, Sterile Technique, and Blood Cultures 2.3 Transport Devices, Atmosphere, Time, and Temperature

3 Preanalytic: Processing, Media, and Incubation

3.1 Prioritization, Rejection, and Specimen Preparation 3.2 Media Types, Components, and Selection 3.3 Inoculation, Incubation Conditions, and Slide Preparation

4 Preanalytic: Stains

4.1 Gram Stain: Procedure, Principle, and Interpretation 4.2 Acid-Fast and Modified Acid-Fast Stains 4.3 KOH, Calcofluor-White, Trichrome, Giemsa, and Acridine Orange

5 Bacteriology: Blood and Bone Marrow

5.1 Blood Culture Systems and Rapid Identification 5.2 Bloodstream Pathogens and Skin Flora Significance 5.3 Endocarditis, Bone Marrow Pathogens, and Pathogenicity

6 Bacteriology: CSF and Sterile Body Fluids

6.1 CSF Sources and Acute Meningitis Pathogens 6.2 Shunt Infections, CSF Correlates, Antigen and Molecular Methods 6.3 Sterile Body Fluids: Pathogens, Flora, and Molecular Methods

7 Bacteriology: Respiratory Tract

7.1 Lower Respiratory Specimens, CAP, and HAP Pathogens 7.2 Cystic Fibrosis Pathogens and Quantitative Reporting 7.3 Upper Respiratory: Pharyngitis, Otitis, Sinusitis, Antigen/Molecular

8 Bacteriology: Gastrointestinal Tract

8.1 Enteric Pathogens: Culture and Colony Morphology 8.2 Clostridioides difficile, Shiga Toxin, and Serotyping 8.3 Helicobacter pylori Detection and GI Pathogenicity

9 Bacteriology: Skin, Soft Tissue, and Bone

9.1 Skin, Soft Tissue, and Bone Pathogens 9.2 Bite Wounds and Zoonotic Infections 9.3 SST Pathogenicity and Virulence Mechanisms

10 Bacteriology: Genital Tract and Urine

10.1 Genital Flora and Vaginitis Pathogens 10.2 Neisseria gonorrhoeae, Chlamydia trachomatis, GBS, and Mycoplasma 10.3 Urinary Pathogens, Colony Counts, and Urinalysis Correlation

11 Bacteriology: Identification Methods

11.1 Colony Morphology and Rapid Presumptive Tests 11.2 Conventional Biochemicals and Commercial Kits 11.3 Automated Methods, MALDI-TOF MS, Molecular, and 16S Sequencing

12 Bacteriology: Antimicrobial Susceptibility and Resistance

12.1 Microbroth Dilution, Disk Diffusion, and Gradient Diffusion 12.2 Phenotypic Detection of Resistance 12.3 Antibiotic Classes, Intrinsic Resistance, and Genetic Markers

13 Bacteriology: Resistance Screening and Select Agents

13.1 MRSA/MSSA, VRE, ESBL/CRE Screening 13.2 BSL-3 Pathogens and Select-Agent Presumptive Identification 13.3 Laboratory Response Network and Select-Agent Pathogenicity

14 Mycobacteriology and Nocardia

14.1 Specimens, Major Pathogens, and Disease States 14.2 Acid-Fast Reaction, Colony Morphology, and Growth Characteristics 14.3 Identification Methods, Direct Molecular Detection, and TB Therapy

15 Virology

15.1 Respiratory, Vesicle, Meningitis, and GI Viruses 15.2 Hepatitis, HIV, and Immunocompromised-Host Viruses 15.3 Direct Detection Methods and HPV Cervical Screening

16 Parasitology

16.1 Blood, Tissue, and Brain Protozoa 16.2 Intestinal/Urogenital Protozoa and Helminths 16.3 Microscopy, Antigen/Molecular Detection, Insects and Arthropods

17 Mycology

17.1 Yeasts: Candida, Cryptococcus, and Malassezia 17.2 Dimorphic Fungi and Dermatophytes 17.3 Mucorales, Hyaline Molds, Pneumocystis, and Identification Methods

18 Serology

18.1 Immunoglobulin Response and Antigen-Antibody Methods 18.2 Viral Serodiagnosis: Hepatitis, EBV, HIV, CMV, Rubella, Measles 18.3 Treponema, Borrelia, and TB Infection Serodiagnosis

19 Laboratory Operations: Postanalytic Procedures and Quality

19.1 Documentation, Critical Values, Corrected Reports, and Public Health 19.2 Quality Control, Root-Cause Analysis, and POCT 19.3 Proficiency Testing, Competency, and Accreditation

20 Laboratory Operations: Safety, Mathematics, and Instrumentation

20.1 Biosafety, PPE, Bloodborne Pathogens, and SDS 20.2 Emergencies and Packaging/Transportation of Specimens 20.3 Laboratory Mathematics and Instrumentation

7.1 Lower Respiratory Specimens, CAP, and HAP Pathogens

Key Takeaways Explain This Topic AI

Screen sputum Gram stains for squamous epithelial cells versus neutrophils; mixed oral flora (viridans streptococci, saprophytic Neisseria, Corynebacterium, coagulase-negative staphylococci, yeast) must not be over-called as pneumonia pathogens.

Community-associated pneumonia organisms on the M outline are Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Legionella pneumophila, and Staphylococcus aureus.

Healthcare-associated pneumonia organisms on the M outline are Acinetobacter baumannii complex, Enterobacteriaceae, Pseudomonas spp., Stenotrophomonas maltophilia, and S. aureus.

Legionella pneumophila requires buffered charcoal yeast extract agar with L-cysteine and survives intracellularly in environmental amoebae and alveolar macrophages.

High-yield virulence facts are the pneumococcal capsule and pneumolysin, device-associated biofilms, and Legionella's intracellular lifestyle.

Last updated: August 2026

7.1 Lower Respiratory Specimens, CAP, and HAP Pathogens

Quick Answer: Expectorated sputum is the most contaminated lower-tract specimen; BAL, bronchial wash, and protected brush are progressively more protected. Do not report viridans streptococci, saprophytic Neisseria, diphtheroids, coagulase-negative staphylococci, or yeast from a poor-quality sputum as pneumonia pathogens. CAP organisms on the M(ASCP) outline are S. pneumoniae , H. influenzae , M. catarrhalis , L. pneumophila , and S. aureus . HAP organisms are A. baumannii complex, Enterobacteriaceae, Pseudomonas spp., S. maltophilia , and S. aureus . Legionella needs BCYE with L-cysteine.

Analytic Procedures for Bacteriology is 45–55% of the M examination. Official outline II.D Lower Respiratory (content guideline revised 2025-09-25 ) is one of the densest specimen-based units in that domain. This section covers sources, oral-flora morphology, community-associated versus healthcare-associated pathogens, molecular methods, and pathogenicity. Quantitative reporting and cystic fibrosis workup are also II.D; they are taught in the next section so this unit can stay focused on how a specimen is collected, whether the Gram stain is trustworthy, and which organisms the outline actually lists.

Specimen sources

A “lower respiratory” culture is only as good as the material that reached the plate. The outline names five sources. They are not interchangeable.

Source How it is obtained Contamination risk Bench implication

Sputum Expectorated or induced cough Highest oropharyngeal mix Screen the Gram stain; reject or qualify dirty specimens

Endotracheal aspirate (ETA) Suction through an endotracheal tube High colonization of the tube Often cultured quantitatively in VAP algorithms

Bronchoalveolar lavage (BAL) Bronchoscope wedges and lavages alveolar space Lower than sputum/ETA Preferred invasive specimen for many VAP and immunocompromised workups

Bronchial wash Saline washed over more proximal airways Intermediate More bronchial than alveolar; still better than raw sputum

Bronchial / protected brush Sheathed brush samples a discrete airway Lowest Small volume, so a lower CFU threshold is used (next section)

Sputum and ETA represent the airway plus whatever lived in the mouth or on the tube. BAL and a protected brush are attempts to sample below that biofilm. When the exam stem says “expectorated sputum with many squamous epithelial cells,” think contamination, not a new pathogen list.

Gram stain quality and oral flora

Before identification work starts, the technologist reads the Gram stain. A useful sputum or ETA smear is rich in neutrophils and shows a predominant morphotype . A smear dominated by squamous epithelial cells is saliva. Many laboratories reject or heavily qualify cultures when squamous cells exceed a validated cutoff (commonly about 10–25 squamous cells per low-power field, depending on the procedure in use). Laboratories follow their validated SOP; the exam point is the principle, not a single magic number.

Oral flora has predictable colony and Gram-stain morphology. Memorize the set the outline cares about:

Oral-flora organism Gram morphology Colony / bench clues Why it is usually not a pneumonia pathogen from sputum

Viridans streptococci Gram-positive cocci in chains Alpha-hemolytic, catalase-negative, optochin-resistant, bile-insoluble Normal oropharynx; do not confuse with pneumococcus

Saprophytic Neisseria Gram-negative diplococci Often yellow, oxidase-positive, grow on blood/chocolate Not N. meningitidis or N. gonorrhoeae without selective workup and clinical context

Corynebacterium (diphtheroids) Club-shaped Gram-positive rods, Chinese-letter arrangements Catalase-positive, dry white-to-gray colonies Skin/mucosal flora; species-level ID is rarely indicated from sputum

Coagulase-negative staphylococci Gram-positive cocci in clusters Catalase-positive, coagulase-negative, white colonies Tube and skin flora; not a CAP/HAP headline organism from mixed sputum

Yeast ( Candida ) Budding yeast, pseudohyphae possible Creamy colonies on blood/chocolate Common oral colonizer; do not auto-report as fungal pneumonia

Do not over-interpret oral flora from sputum. A mixed Gram stain with squamous cells is not “five pathogens.” Report the quality issue, recover true lower-tract pathogens if a predominant morphotype is present, and leave the mouth organisms in the flora comment.

Community-associated pneumonia pathogens

The outline’s CAP list is short and testable. These organisms are acquired outside the hospital (or very early after admission) in patients without the classic healthcare-associated risk set.

Organism Gram / growth High-yield ID Clinical hook

Streptococcus pneumoniae Lancet-shaped Gram-positive diplococci Alpha-hemolytic, catalase-negative, optochin susceptible , bile soluble ; mucoid if heavily encapsulated (classically type 3) Lobar pneumonia; rust-colored sputum historically; capsule and pneumolysin

Haemophilus influenzae Pleomorphic Gram-negative coccobacilli Chocolate agar , X (hemin) and V (NAD), satellitism around S. aureus , no growth on MacConkey Nontypeable strains dominate adult CAP; type b remains a concern in unvaccinated children

Moraxella catarrhalis Gram-negative diplococci Oxidase-positive, hockey-puck colonies that slide across agar, tributyrin/butyrate-esterase positive Otitis/sinusitis overlap; almost all isolates produce beta-lactamase

Legionella pneumophila Poorly staining Gram-negative rod; often not seen on routine Gram stain Does not grow on sheep blood or ordinary chocolate ; needs BCYE with L-cysteine Aerosolized water systems; severe CAP; urine antigen (serogroup 1) and PCR

Staphylococcus aureus Gram-positive cocci in clusters Catalase-positive, coagulase-positive, beta-hemolytic; yellow on mannitol salt Post-influenza necrotizing/cavitary pneumonia; MRSA is a CAP and HAP problem

S. pneumoniae versus viridans streptococci is a classic trap. Both are alpha-hemolytic catalase-negative cocci. Pneumococcus is optochin susceptible and bile soluble; viridans organisms are not. A lancet-shaped diplococcus inside neutrophils on a quality sputum smear is a reportable clue, not a reason to identify every alpha-hemolytic colony from a dirty specimen.

H. influenzae is missed when the bench plants only blood and MacConkey agar. Chocolate (or a V-factor source on blood agar) is required. The porphyrin/ALA test is negative for H. influenzae because it cannot make hemin from ALA and therefore needs exogenous X factor.

Healthcare-associated pneumonia pathogens

HAP (including ventilator-associated pneumonia) is a different ecology: hospital water and surfaces, endotracheal-tube biofilm, and prior antibiotics that select multidrug-resistant Gram-negative rods. S. aureus appears on both lists.

Organism Bench clues Why it belongs on the HAP list

Acinetobacter baumannii complex Oxidase- negative Gram-negative coccobacillus; grows on MacConkey; survives dry surfaces ICU outbreaks, ventilators, and wounds; not a typical CAP organism

Enterobacteriaceae MacConkey growth; oxidase-negative; K. pneumoniae often mucoid Aspiration of GI flora; Klebsiella , E. coli , Enterobacter , Serratia , Proteus

Pseudomonas spp. Oxidase-positive; P. aeruginosa may show grape/tortilla odor, metallic sheen, pyocyanin, growth at 42 °C Device biofilm, neutropenia, CF (next section), wet hospital environments

Stenotrophomonas maltophilia Oxidase-negative (or weak), maltose oxidizer, not a true Pseudomonas Intrinsic carbapenem resistance (L1 metallo-beta-lactamase); TMP-SMX is the usual first-line agent

S. aureus Same ID as in CAP Ventilator and postoperative pneumonia; MRSA screening and molecular markers

Oxidase is a sorting hat. P. aeruginosa is oxidase-positive. A. baumannii and S. maltophilia are oxidase-negative, so they are not “another Pseudomonas.” S. maltophilia oxidizes maltose and is a classic late pathogen in patients who have already received carbapenems.

A mucoid Gram-negative rod on MacConkey from a hospital pneumonia is more likely K. pneumoniae or mucoid P. aeruginosa than pneumococcus. Pneumococcus does not grow on MacConkey agar.

Loading diagram... Lower-respiratory specimen quality, CAP versus HAP, and Legionella workup

Legionella and BCYE

Legionella pneumophila is the CAP organism that will not announce itself on a routine sheep-blood plate. It is fastidious, stains poorly with Gram stain, and needs buffered charcoal yeast extract (BCYE) agar. Yeast extract supplies nutrients, charcoal binds inhibitors, ACES buffer holds the pH, ferric pyrophosphate supplies iron, and L-cysteine is essential . A cysteine-deficient control plate is a classic identity check: Legionella grows on BCYE with cysteine and fails without it. Colonies are often gray-white and ground-glass after 3–5 days , so a 24-hour “no growth” reading is not a Legionella culture.

Selective BCYE formulations (PAC, BMPA, and similar antibiotic combinations) reduce competing flora from sputum. Even then, a protected lower-tract specimen or a PCR/urine-antigen test is often more practical than waiting on a heavily mixed sputum. Urinary antigen detects serogroup 1 , which causes most community disease but not every species or serogroup. Direct fluorescent antibody and molecular assays broaden the net. Culture remains useful for outbreak investigation and uncommon species.

Molecular methods

Molecular testing is on the lower-respiratory outline because culture is slow and incomplete for atypicals. Syndromic pneumonia panels can detect S. pneumoniae , H. influenzae , L. pneumophila , S. aureus (often with mecA/mecC and MREJ for MRSA), and selected resistance genes. Legionella PCR covers more than urine antigen. Pneumococcal urinary antigen is a rapid adjunct in adult CAP.

Molecular results do not replace culture when a viable isolate is needed for susceptibility testing, and they do not automatically equal invasive disease. Panels detect nucleic acid from colonizers as well as pathogens, especially Enterobacterales, P. aeruginosa , and S. aureus in intubated patients. Off-panel organisms still require the plate. Report molecular findings with the Gram stain, the specimen type, and the culture so clinicians are not treating DNA from oral flora.

Pathogenicity the exam expects

Four virulence stories are enough for M-level respiratory bacteriology.

Capsule. S. pneumoniae is the prototype: antiphagocytic polysaccharide capsule, Quellung reaction, and the reason optochin/bile tests matter. Encapsulated H. influenzae type b and mucoid K. pneumoniae use the same general strategy.

Pneumolysin. This cholesterol-dependent cytolysin of S. pneumoniae pores host membranes, injures ciliated epithelium, and activates complement. It is a CAP virulence fact, not a media ingredient.

Biofilm. P. aeruginosa and S. aureus coat endotracheal tubes and airway devices. Biofilm explains why ETA cultures grow colonizers, why VAP is hard to clear, and why a protected specimen with a quantitative threshold is more specific than an untimed swab of the tube.

Intracellular Legionella. In water systems, L. pneumophila replicates inside free-living amoebae . In the lung it enters alveolar macrophages and lives in a specialized vacuole. Person-to-person spread is not the usual route; aerosolized water is. That intracellular lifestyle is why the organism is protected in the environment, why it does not grow on ordinary agar, and why cell-mediated immunity matters clinically.

Put the pieces together on exam day: a dirty sputum full of mixed oral flora is not a CAP panel; a lancet-shaped diplococcus in neutrophils is pneumococcus until proven otherwise; an oxidase-negative nonfermenter from a ventilator is not Pseudomonas ; and a severe CAP with hyponatremia and a water-exposure history still needs BCYE or a Legionella molecular/antigen test even when the blood agar is blank.